Timbuktu Capital Management, LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 2150168
BOSTON, MA
Position in REGN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$53,000
New position
Shares Held
85
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#1,121
of 1,322 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Timbuktu Capital Management, LLC holds $53,500 across 2 Biotechnology names. REGN ranks #1 (99.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
85 | $53,000 | |
| 2 | KRRO |
Korro Bio, Inc.
|
38 | $500 |
All Filings in REGN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $53,000 | 85 | Shares | Sole | 2026-08-13 | |
| No filing history on record for this holder in this stock. | ||||||